Skip to main content
Joyson Karakunnel, MD, Oncology, Bethesda, MD

JoysonKarakunnelMDMS, FACP

Oncology Bethesda, MD

Hematologic Oncology, Hospice & Palliative

Staff Hematologist-Oncologist

Dr. Karakunnel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Karakunnel's full profile

Already have an account?

Education & Training

  • University of Maryland
    University of MarylandMS, Pharmacology, 2005 - 2008
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008
  • University of Maryland
    University of MarylandFellowship, Hematology and Medical Oncology, 2005 - 2006
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Hospice and Palliative Medicine, 2005
  • Atlantic Health System/Overlook Medical Center
    Atlantic Health System/Overlook Medical CenterResidency, Internal Medicine, 2000 - 2003
  • Rajah Muthiah Medical College
    Rajah Muthiah Medical CollegeClass of 2000

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2005 - 2020
  • CA State Medical License
    CA State Medical License 2017 - 2019
  • WI State Medical License
    WI State Medical License 2012 - 2017
  • DC State Medical License
    DC State Medical License 2015 - 2016
  • MD State Medical License
    MD State Medical License 2003 - 2016
  • KY State Medical License
    KY State Medical License 2013 - 2014
  • ME State Medical License
    ME State Medical License 2012 - 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab in Mycosis Fungoides
    Innate Pharma Presents Preliminary Data from TELLOMAK Trial Showing Clinical Response for Lacutamab in Mycosis FungoidesJune 22nd, 2021
  • Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
    Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business UpdateMay 3rd, 2021
  • Innate Pharma Announces Conference Call and Webcast for Full Year 2020 Financial Results
    Innate Pharma Announces Conference Call and Webcast for Full Year 2020 Financial ResultsMarch 15th, 2021
  • Join now to see all